A Drouillard, P Puleo, J B Bachet, S Ouazzani, A Calomme, et al.. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer..
British Journal of Cancer, Cancer Research UK, 2016, 115 (10), pp.1245-1252.
⟨10.1038/bjc.2016.319⟩.
⟨hal-01430664⟩